NCT01624649View on ClinicalTrials.gov

A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors

CompletedOBSERVATIONAL

Enrollment

289

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Attention-deficit Hyperactivity Disorder

Interventions

DRUG

Methylphenidate hydrochloride

Form = tablet, route = oral, administered as a flexible dosage

DRUG

Atomoxetine

Form = tablet, route = oral;

Trial Locations (9)

Unknown

Bucheon-Si Gyeonggi-Do

Daegu

Gyeongsangnam-Do

Jeju Special Self-Governing Province

Jeonju

Kyunggi-Do

Seongnam

Seoul

Suwon

All Listed Sponsors

lead

Janssen Korea, Ltd., Korea

INDUSTRY

NCT01624649 - A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors | Biotech Hunter | Biotech Hunter